Besremi Achieves Strong Market Growth Amid Rising Demand For Polycythemia Vera Treatment
BESREMi is a preferred, FDA-approved option for both symptomatic low- and high-risk polycythemia vera patients. In the polycythemia vera space, BESRE ...